top of page

Industry News

2025-01-23

Financial Times

Investors lose their appetite for the obesity trade

2025-01-14

Science

Is obesity a disease? Not always, new expert report says

2024-10-10

BiopharmaDive

Drugmakers are racing to find the next Wegovy. These obesity trials are ones to watch.

2024-10-10

PharmaVoice

How Madrigal plans to win on the market with the first MASH drug

2024-10-07

PharmaVoice

Novo’s GLP-1 Wegovy could improve heart health for millions more than previously thought, AI study finds

2024-10-03

BiopharmaDive

FDA makes end of Zepbound, Mounjaro shortage official

2024-10-03

Wall Street Journal

For Hims & Hers Stock, GLP-1 Giveth and GLP-1 Taketh Away

2024-10-01

BiopharmaDive

Kailera Therapeutics emerges from stealth with $400M for obesity drugs

2024-09-24

STATNews

Sanders says PBMs won’t penalize Novo for cutting Ozempic, Wegovy prices

2024-09-19

STAT News

Corbus sees Novo’s controversial obesity approach as a ticket to a blockbuster

2024-09-19

STAT News

Long-overlooked scientist shares Lasker Award with other GLP-1 researchers

2024-09-17

STAT News

Pediatricians’ obesity guidelines rest on shaky evidence about eating disorder risks

bottom of page